These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
616 related items for PubMed ID: 23619261
1. Impact of MELD score implementation on liver allocation: experience at a Brazilian center. da Silva Machado AG, de Medeiros Fleck A, Marroni C, Zanotelli ML, Cantisani G, de Mello Brandão AB. Ann Hepatol; 2013; 12(3):440-7. PubMed ID: 23619261 [Abstract] [Full Text] [Related]
2. Consequences of the implementation of the Model for End-stage Liver Disease system for liver allocation in Brazil. Pestana RC, Baracat EI, Massarollo PC, Pereira LA, Szutan LA. Transplant Proc; 2013; 45(6):2111-4. PubMed ID: 23747144 [Abstract] [Full Text] [Related]
3. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality. Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH. Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574 [Abstract] [Full Text] [Related]
4. Model for end-stage liver disease-based allocation system for liver transplantation in Argentina: does it work outside the United States? McCormack L, Gadano A, Lendoire J, Imventarza O, Andriani O, Gil O, Toselli L, Bisigniano L, de Santibañes E. HPB (Oxford); 2010 Sep; 12(7):456-64. PubMed ID: 20815854 [Abstract] [Full Text] [Related]
5. The MELD system and liver transplant waiting-list mortality in developing countries: lessons learned from São Paulo, Brazil. Salvalaggio P, Afonso RC, Pereira LA, Ferraz-Neto BH. Einstein (Sao Paulo); 2012 Sep; 10(3):278-85. PubMed ID: 23386004 [Abstract] [Full Text] [Related]
6. Waiting time predicts survival after liver transplantation for hepatocellular carcinoma: a cohort study using the United Network for Organ Sharing registry. Schlansky B, Chen Y, Scott DL, Austin D, Naugler WE. Liver Transpl; 2014 Sep; 20(9):1045-56. PubMed ID: 24838471 [Abstract] [Full Text] [Related]
7. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy. Cejas NG, Villamil FG, Lendoire JC, Tagliafichi V, Lopez A, Krogh DH, Soratti CA, Bisigniano L. Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946 [Abstract] [Full Text] [Related]
8. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy. Gadiparthi C, Cholankeril G, Yoo ER, Hu M, Wong RJ, Ahmed A. Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079 [Abstract] [Full Text] [Related]
9. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores. Chok KSh, Chan SC, Fung JY, Cheung TT, Chan AC, Fan ST, Lo CM. Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):256-62. PubMed ID: 23742770 [Abstract] [Full Text] [Related]
12. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. Vitale A, Volk ML, De Feo TM, Burra P, Frigo AC, Ramirez Morales R, De Carlis L, Belli L, Colledan M, Fagiuoli S, Rossi G, Andorno E, Baccarani U, Regalia E, Vivarelli M, Donataccio M, Cillo U, Liver Transplantation North Italy Transplant program (NITp) working group. J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408 [Abstract] [Full Text] [Related]
14. Prioritization for liver transplantation using the MELD score in Chile: Inequities generated by MELD exceptions.: A collaboration between the Chilean Liver Transplant Programs, the Public Health Institute and the National Transplant Coordinator. Díaz LA, Norero B, Lara B, Robles C, Elgueta S, Humeres R, Poniachik J, Silva G, Wolff R, Innocenti F, Rojas JL, Zapata R, Hunter B, Álvarez S, Cancino A, Ibarra J, Rius M, González S, Calabrán L, Pérez RM. Ann Hepatol; 2019 Feb; 18(2):325-330. PubMed ID: 31010794 [Abstract] [Full Text] [Related]
15. Increasing the donor pool reduces the severity of liver disease: lessons learned from São Paulo, Brazil. Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH. Transplant Proc; 2012 Oct; 44(8):2286-8. PubMed ID: 23026575 [Abstract] [Full Text] [Related]
16. Survival outcomes in liver transplant recipients with Model for End-stage Liver Disease scores of 40 or higher: a decade-long experience. Panchal HJ, Durinka JB, Patterson J, Karipineni F, Ashburn S, Siskind E, Ortiz J. HPB (Oxford); 2015 Dec; 17(12):1074-84. PubMed ID: 26373873 [Abstract] [Full Text] [Related]
17. Developments in pediatric liver transplantation since implementation of the new allocation rules in Eurotransplant. Herden U, Grabhorn E, Briem-Richter A, Ganschow R, Nashan B, Fischer L. Clin Transplant; 2014 Sep; 28(9):1061-8. PubMed ID: 25040668 [Abstract] [Full Text] [Related]
18. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system. Genda T, Ichida T, Sakisaka S, Sata M, Tanaka E, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y. J Gastroenterol; 2014 Feb; 49(2):324-31. PubMed ID: 23478939 [Abstract] [Full Text] [Related]
19. Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation. Gotthardt D, Weiss KH, Baumgärtner M, Zahn A, Stremmel W, Schmidt J, Bruckner T, Sauer P. BMC Gastroenterol; 2009 Sep 25; 9():72. PubMed ID: 19778459 [Abstract] [Full Text] [Related]
20. Serum hypoalbuminemia predicts late mortality on the liver transplant waiting list. Porrett PM, Baranov E, ter Horst M. Transplantation; 2015 Jan 25; 99(1):158-63. PubMed ID: 25050469 [Abstract] [Full Text] [Related] Page: [Next] [New Search]